Reference health
Toll‐like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?
71/71 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 71 checked references that resolve
resolves10.1016/j.autrev.2012.02.002
Common mechanisms of autoimmune diseases (the autoimmune tautology)
resolves10.1038/ni.1863
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
resolves10.1111/j.1600-065X.2012.01115.x
Contribution of Toll‐like receptor signaling to germinal center antibody responses
resolves10.4049/jimmunol.1401720
B Cell–Intrinsic TLR7 Signaling Is Essential for the Development of Spontaneous Germinal Centers
resolves10.2147/ITT.S89795
Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments
resolves10.1111/j.1365-2249.2008.03646.x
Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
resolves10.1126/science.1124978
Autoreactive B Cell Responses to RNA-Related Antigens Due to
<i>TLR7</i>
Gene Duplication
resolves10.1016/j.jneuroim.2011.08.010
Targeting Toll-like receptors: Emerging therapeutics for multiple sclerosis management
resolves10.1007/s10753-012-9526-6
Possible Involvement of Toll-Like Receptors in the Pathogenesis of Myasthenia Gravis
resolves10.1016/S0002-9440(10)62960-4
Increased Toll-Like Receptor 4 Expression in Thymus of Myasthenic Patients with Thymitis and Thymic Involution
resolves10.1007/s12016-016-8549-4
Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models
resolves10.1002/ana.23791
Implication of double‐stranded RNA signaling in the etiology of autoimmune myasthenia gravis
resolves10.1016/j.jaut.2013.12.013
Innate immunity in myasthenia gravis thymus: Pathogenic effects of Toll-like receptor 4 signaling on autoimmunity
resolves10.1016/j.imbio.2015.12.007
Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein–Barr virus infection
resolves10.1016/j.autrev.2013.03.007
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
resolves10.1016/S0022-510X(03)00087-X
Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up
resolves10.4049/jimmunol.174.10.5941
Effects of Cytokines on Acetylcholine Receptor Expression: Implications for Myasthenia Gravis
resolves10.1016/j.jneuroim.2008.06.028
Thymus and Myasthenia Gravis: What can we learn from DNA microarrays?
resolves10.1016/j.imbio.2012.05.006
SDF-1/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients
resolves10.1111/j.1440-1711.2005.01331.x
Immune responses to dsRNA: Implications for gene silencing technologies
resolves10.1212/WNL.0b013e3181d7d884
Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis
resolves10.1002/ana.21902
Epstein‐Barr virus persistence and reactivation in myasthenia gravis thymus
resolves10.3390/v4123701
Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation
resolves10.1084/jem.20071030
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
resolves10.1093/brain/awr197
Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria
resolves10.1136/annrheumdis-2012-202352
Epstein–Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis
resolves10.1111/j.1468-1331.2011.03636.x
High anti‐EBNA‐1 IgG levels are associated with early‐onset myasthenia gravis
resolves10.1016/j.imbio.2016.06.012
A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patients
resolves10.1016/j.virol.2014.10.030
Unexpected patterns of Epstein–Barr virus transcription revealed by a High throughput PCR array for absolute quantification of viral mRNA
resolves10.1084/jem.20081761
Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3
resolves10.1128/JVI.01122-07
Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus
resolves10.4049/jimmunol.177.5.2793
EBV Latent Membrane Protein 2A Induces Autoreactive B Cell Activation and TLR Hypersensitivity
resolves10.4049/jimmunol.0903736
TLR9 Contributes to the Recognition of EBV by Primary Monocytes and Plasmacytoid Dendritic Cells
resolves10.1128/JVI.01400-09
Toll-Like Receptor Agonists Synergistically Increase Proliferation and Activation of B Cells by Epstein-Barr Virus
resolves10.1002/art.27408
Epstein‐Barr virus promotes interferon‐α production by plasmacytoid dendritic cells
resolves10.1136/ard.2007.086421
Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA)
resolves10.1002/eji.201242985
<scp>TLR</scp>7 signaling exacerbates <scp>CNS</scp> autoimmunity through downregulation of <scp>F</scp>oxp3<sup>+</sup><scp>T</scp>reg cells
resolves10.1038/icb.2016.55
Interferon‐β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS‐mediated apoptosis
resolves10.1212/WNL.0b013e31821f440a
Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies
resolves10.1002/eji.200535744
Toll‐like receptor stimulation as a third signal required for activation of human naive B cells
resolves10.1038/nri2358
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
resolves10.1016/j.jaut.2013.12.018
Thymoma-associated myasthenia gravis: On the search for a pathogen signature
resolves10.18632/oncotarget.20731
Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?
resolves10.1093/emboj/17.6.1700
Epstein–Barr virus‐mediated B‐cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor
resolves10.1016/j.autrev.2013.03.011
Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis
resolves10.1002/eji.201242552
EBV stimulates TLR‐ and autophagy‐dependent pathways and impairs maturation in plasmacytoid dendritic cells: Implications for viral immune escape
resolves10.1371/journal.pone.0043317
Toll-Like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1
resolves10.1016/j.jaut.2013.12.016
Central role of interferon-beta in thymic events leading to myasthenia gravis
resolves10.1371/journal.pone.0070626
Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells
resolves10.1182/blood-2011-04-348839
TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway
resolves10.1016/j.clim.2016.09.015
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis
resolves10.1038/cmi.2015.13
Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation
resolves10.1038/ncomms7119
Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases
resolves10.1016/j.autrev.2015.07.006
Gene/environment interactions in the pathogenesis of autoimmunity: New insights on the role of Toll-like receptors
The 2 references without a DOI — listed, not checked
no DOI — not checkedRole of toll‐like receptors in multiple sclerosis
no DOI — not checkedInflammation and Epstein–Barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesis
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1111/nyas.13534"><img src="https://citestamp.com/citestamped/10.1111/nyas.13534/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1111/nyas.13534)